Paul Duic, M.D., is a Neuro-Oncologist. He specializes in the medical management of brain tumors and spine tumors, including central nervous system (CNS) tumors, gliomas, metastatic tumors, and CNS lymphoma.

Dr. Duic received his undergraduate degree, Bachelor of Sciences, in Biological Sciences, from Columbia University, New York, NY magna cum laude. He obtained his medical degree at NYU School of Medicine, New York, NY.

Dr. Duic completed a Residency in Emergency Medicine at Johns Hopkins University. He also completed a Surgical Internship and three years of Neurological Surgery Residency at UC Davis Medical Center, Sacramento, CA. He subsequently completed a Fellowship in Neuro-Oncology at the Neuro-Oncology Branch of the National Cancer Institute, National Institutes of Health (NIH.) He returned to the Neuro-Oncology Branch of NIH before joining Neurological Surgery, P.C.

Dr. Duic has also served as a Lieutenant Commander in the Medical Corps of the United States Naval Reserve.

Dr. Duic published “Central Nervous System Tumors” in the Bethesda Handbook of Clinical Oncology. He has several manuscripts in preparation, including:“Selective Glioma Targeting by a Recombinant Adeno-Associated Virus Type 5 Vector,” and “Phase I Study of CC-8490, a Selective Estrogen Receptor Modulator, in Patients With Recurrent Malignant Gliomas and Progressive, Diffuse, Infi ltrating Gliomas.” He is an experienced co-investigator on multiple clinical trials at NIH involving many novel molecularly targeted agents. He has delivered neurosurgical grand rounds and spoken on several other occasions regarding these clinical trials, such as “The Development of Enzastaurin for Malignant Gliomas.”